• Psychedelic Therapies Enter a Crucial Phase as Clinical Research Accelerates

    Clinical Research News | As psychedelic and dissociative-based medications pick up more interest, they may enter mainstream psychiatry in the coming years. Though ketamine and psilocybin are highlighted for their potential, their mechanisms—and side effects—still require further investigation.

    Dec 16, 2025

  • 2026 Participant Engagement Award Finalists Address Pediatric Patients; Lupus; Vaccine Trials; Recruitment Issues

    Clinical Research News | Finalists have been announced in the 10th annual Participant Engagement Awards. Four projects from Biogen, Proximity Health Solutions, and BlackDoctor.org; Empath Labs; PACT; and Science 37 and RxE2 will be presented during a live judging session at SCOPE in Orlando, Florida, Feb 2-5, 2026.

    Dec 11, 2025

  • The Scope of Things: Practical Regulations Strategies for Clinical Efficiency

    Clinical Research News | The FDA’s decades-old regulation 21 CFR Part 11—which establishes criteria for electronic records and signatures to be considered trustworthy and equivalent to paper records—is in dire need of an update. Doug Bain, founder and consulting partner of ClinFlo, has his own proposal on reformations to streamline clinical trials and improve experiences for patients, sites, and sponsors, which he discusses extensively in this month’s episode of the Scope of Things.

    Dec 9, 2025

  • Statistical Considerations in Decentralized Clinical Trials

    Clinical Research News | Decentralized clinical trials (DCTs) aim to harness the power of technology to lower the burden of clinical trial participation, increase engagement and improve outreach and diversity. However, for these benefits to be realized, we need to understand the specific challenges created by DCTs and how to mitigate them.

    Dec 5, 2025

  • Next-Generation Immunotherapy Nears the Clinic with Dual Cancer Trials

    Clinical Research News | Glycans are the complex sugar chains found at abnormally high levels on the surface of cancer cells—and one of the toughest challenges in cancer treatment. A research team from the UC Irvine School of Medicine developed glycan-dependent T cell recruiters (GlyTRs), which represent a first-of-its-kind approach that bypasses traditional antibody mechanisms to attack cancer’s sugar-coated armor.

    Dec 3, 2025

  • Space Health Research Could Rack Up Many Earthly Dividends

    Clinical Research News | When the first all-civilian spaceflight, Inspiration4, was launched by SpaceX in 2021, it set into orbit the idea of future space habitation. It also marked the start of a long-term mission to understand the impact of the journey on everyday people without extensive astronaut training.

    Dec 2, 2025